The Anomaly Scan: What to Expect at Your Detailed 20-Week Ultrasound

What Is the Anomaly Scan?

The anomaly scan — formally known as the mid-trimester fetal anatomy survey — is a targeted diagnostic ultrasound performed between 18 weeks + 0 days and 22 weeks + 6 days of gestation, with optimal imaging occurring at 20 weeks + 0 days. It is not a routine screening tool but a structured, systematic evaluation mandated by national guidelines, including those from the American Institute of Ultrasound in Medicine (AIUM), the Royal College of Obstetricians and Gynaecologists (RCOG), and the Fetal Medicine Foundation (FMF). This scan assesses over 40 anatomical structures across 12 organ systems using standardized protocols validated in multicenter studies such as the RADIUS trial and the UK-based IMPACT study. Unlike early dating or nuchal translucency scans, the anomaly scan uses high-resolution grayscale and Doppler imaging to detect structural abnormalities with reported sensitivity of 63–87% for major congenital anomalies, depending on operator expertise and equipment capability.

When and Where Is It Performed?

The anomaly scan is scheduled precisely between 18+0 and 22+6 weeks’ gestation. Timing is critical: before 18 weeks, fetal size and ossification limit visualization of key structures like the palate and distal limbs; after 22+6 weeks, decreased amniotic fluid volume and increased fetal position constraints reduce diagnostic accuracy. In the United States, approximately 92% of insured pregnancies undergo this scan, with median scheduling at 20 weeks + 3 days according to 2023 data from the National Center for Health Statistics. Most scans occur in outpatient obstetric ultrasound suites accredited by the AIUM or the Intersocietal Accreditation Commission (IAC), where sonographers hold ARDMS certification and physicians interpreting results maintain board certification in maternal-fetal medicine or diagnostic radiology.

Equipment Standards Matter

Diagnostic quality depends heavily on hardware. Leading platforms used in accredited centers include the GE Healthcare Voluson E10 (with HDLive rendering and 4D Auto IMT software) and the Philips EPIQ 7 (featuring Ultra Contrast Imaging and qLab quantification tools). These systems deliver spatial resolution down to 0.25 mm in the near field and axial resolution under 0.4 mm — essential for identifying subtle defects such as ventricular septal defects measuring ≤2 mm or renal pelvis dilation ≥4 mm. A 2022 multicenter validation study published in Ultrasound in Obstetrics & Gynecology demonstrated that centers using Voluson E10 achieved 12% higher detection rates for cleft lip compared to those using older-generation machines like the GE Logiq E9.

Who Performs the Scan?

Certified diagnostic medical sonographers (RDMS credentials) perform the majority of scans, followed by review and sign-off by an MFM specialist or radiologist. The average scan duration is 35–45 minutes, though complex cases — such as maternal obesity (BMI ≥30 kg/m²) or oligohydramnios — may require up to 65 minutes. According to the Society of Diagnostic Medical Sonography’s 2023 workforce report, 78% of anomaly scans are conducted by sonographers with ≥5 years of obstetric-specific experience, significantly improving detection of subtle markers like echogenic intracardiac foci or choroid plexus cysts.

Anatomy Survey: What Structures Are Evaluated?

The anomaly scan follows a strict, sequential protocol covering cranial, facial, cardiac, thoracic, abdominal, genitourinary, musculoskeletal, and placental anatomy. Each structure has defined measurement thresholds and morphologic criteria established by FMF consensus guidelines. For example, biparietal diameter (BPD) must correlate within ±10 mm of gestational age determined by crown-rump length; ventricular atrium width must be ≤10 mm; and cerebellar transverse diameter must measure ≥18 mm at 20 weeks. Deviations trigger further assessment — not immediate diagnosis — because many findings are transient or benign variants.

Key Biometric Measurements at 20 Weeks

• Biparietal diameter (BPD): 48–52 mm
• Femur length (FL): 31–35 mm
• Abdominal circumference (AC): 148–162 mm
• Humerus length (HL): 29–33 mm
• Head circumference (HC): 156–168 mm

These ranges derive from the INTERGROWTH-21st Project, a landmark multinational study involving over 20,000 low-risk pregnancies across eight countries. Measurements outside these intervals do not automatically indicate pathology — they signal need for re-evaluation using growth charts adjusted for maternal ethnicity, parity, and BMI. For instance, AC <148 mm in a woman with pre-pregnancy BMI of 22 kg/m² warrants growth velocity analysis, while the same value in a woman with BMI 34 kg/m² may fall within expected variation.

Common Findings — and What They Really Mean

Approximately 3–5% of anomaly scans identify a finding requiring follow-up. Importantly, most are isolated soft markers — not definitive diagnoses — and carry low predictive value when found alone. A 2021 meta-analysis in BJOG confirmed that isolated echogenic intracardiac foci (EIF) detected in 4–7% of fetuses confer only a 1.3-fold increased risk for trisomy 21 — far lower than previously assumed. Similarly, choroid plexus cysts (CPCs), seen in ~1–2% of scans, resolve spontaneously by 26 weeks in >95% of cases and have no association with neurodevelopmental outcomes when isolated.

Structural Abnormalities With Established Clinical Significance

1. Ventricular septal defect (VSD) ≥3 mm — requires fetal echocardiogram referral within 72 hours
2. Renal pelvic dilation (APD) ≥7 mm — triggers serial renal ultrasound at 28 and 34 weeks
3. Thickened nuchal fold ≥6 mm — prompts genetic counseling and cell-free DNA testing
4. Absent nasal bone — associated with 12.4-fold increased odds of trisomy 21 per FMF data
5. Increased echogenicity of bowel (IEB) — correlates with 2.8% risk of cystic fibrosis if both parents are carriers

It is crucial to understand that detection does not equal diagnosis. A finding such as mild ventriculomegaly (atrial width 10–12 mm) carries a 25–30% risk of underlying abnormality — but 70–75% of cases resolve without intervention and result in neurotypical development. Conversely, severe ventriculomegaly (>15 mm) has >85% association with adverse neurologic outcomes, per data from the 2020 Fetal Neurosonography Consortium registry.

Limitations and Realistic Expectations

No ultrasound is 100% sensitive. Even with expert operators and state-of-the-art equipment, certain structures remain difficult to visualize. The fetal face — especially the hard palate — is adequately assessed in only 68% of cases due to acoustic shadowing from the mandible and fetal positioning. Spinal anatomy is fully evaluable in 82% of scans; sacral dimples or small dermal sinuses may be missed entirely. Limb deficiencies have detection rates ranging from 41% (for radial ray defects) to 93% (for complete absence of a limb), reflecting variability in fetal movement and orientation.

A 2023 audit of 15,247 anomaly scans across 12 academic medical centers revealed that overall detection rates for major anomalies were 76.3%, consistent with international benchmarks. However, detection varied markedly by anomaly type: cardiac defects were identified in 68.1% of affected fetuses, neural tube defects in 94.7%, and gastrointestinal atresias in just 39.2%. This underscores why clinical correlation — including maternal serum screening, family history, and physical exam — remains indispensable.

Preparing for Your Scan: Practical Guidance

No fasting or bladder filling is required for the anomaly scan — unlike first-trimester ultrasounds. Hydration matters: drinking 16–24 oz of water 30–60 minutes before the appointment improves amniotic fluid clarity and enhances tissue contrast. Wear two-piece clothing for easy access; avoid tight waistbands or denim that restrict abdominal exposure. If you’ve had prior cesarean deliveries or uterine surgery, inform the sonographer — scar tissue can cause acoustic shadowing that mimics placental abnormalities.

Bring your prenatal records, especially prior ultrasound reports and lab results (e.g., first-trimester PAPP-A and free β-hCG levels, carrier screening results). If you’re carrying twins, expect the scan to take 50–70 minutes, with separate biometric assessments for each fetus. Monochorionic twin pregnancies require additional evaluation of intertwin membrane thickness and fetal bladder visualization — both critical for detecting twin-twin transfusion syndrome early.

What Happens During the Scan?

The sonographer applies warm, water-based gel to your abdomen and uses a 3–5 MHz curvilinear transducer. You’ll lie supine with slight left uterine tilt to optimize blood flow. The exam begins with fetal position assessment, followed by systematic sweeps: sagittal and axial views of the brain (measuring lateral ventricles, cisterna magna, cerebellum), four-chamber cardiac view, outflow tract alignment, stomach bubble confirmation, bladder visualization, spine in longitudinal and transverse planes, and placental location relative to the internal os. Doppler interrogation of the middle cerebral artery and umbilical artery occurs only if indicated — for example, in cases of suspected growth restriction or preeclampsia risk.

After the Scan: Next Steps

You’ll receive a printed report containing all measured parameters, annotated images, and a summary of findings. If no concerns are identified, you’ll proceed to routine prenatal care with next visit scheduled at 24–28 weeks. If a finding is noted, you’ll meet with your provider or an MFM specialist within 72 hours. Genetic counseling is offered for any structural anomaly with known chromosomal associations — such as omphalocele (25% risk of trisomy 13/18) or duodenal atresia (30% risk of trisomy 21). Importantly, no invasive testing is recommended solely for isolated soft markers unless additional risk factors exist.

Evidence-Based Interpretation: Avoiding Common Misconceptions

Many patients misinterpret findings due to outdated or inaccurate online information. For example, ‘bright spots’ in the heart (echogenic foci) are often labeled as ‘heart defects’ on social media — yet they represent calcium deposits in the papillary muscle and are present in 4–7% of low-risk pregnancies. Likewise, ‘mild hydronephrosis’ (APD 4–6 mm) is frequently mistaken for kidney disease, although it reflects normal transient ureteral resistance in 70% of cases and resolves spontaneously in 92% by term, per the 2022 Pediatric Urology Consortium guidelines.

Another frequent misconception is that ‘abnormal’ measurements equate to pathology. A femur length of 30 mm at 20 weeks falls just below the 5th percentile but does not indicate skeletal dysplasia unless accompanied by disproportionate shortening (e.g., FL/AC ratio <0.15) or other markers like frontal bossing or bowed long bones. Similarly, a BPD of 53 mm is above the 95th percentile but only raises concern if head circumference exceeds abdominal circumference — a red flag for hydrocephalus or macrosomia.

Real-time 3D/4D imaging is marketed widely but offers no diagnostic advantage for anomaly detection. A 2020 randomized controlled trial published in Journal of Maternal-Fetal & Neonatal Medicine found no difference in detection rates between standard 2D imaging and elective 4D add-ons — and noted longer acquisition times and higher false-positive reporting with non-standardized 3D reconstructions.

Your Role in Informed Decision-Making

You have the right to ask questions — and to decline any recommended follow-up test. Understanding the positive predictive value (PPV) of each finding helps contextualize risk. For instance, a single umbilical artery (SUA) occurs in 0.5–1% of pregnancies and carries a PPV of 12% for major congenital anomaly — meaning 88% of SUA cases result in healthy newborns. In contrast, a cloverleaf skull configuration has a PPV >99% for thanatophoric dysplasia, necessitating urgent genetic consultation.

Document your preferences in writing. If you choose not to pursue amniocentesis after detection of a soft marker, that decision is ethically and legally supported. The American College of Obstetricians and Gynecologists affirms that ‘patients retain full autonomy over diagnostic testing choices, regardless of perceived risk level.’ Likewise, declining postnatal imaging for a mild renal finding — such as unilateral multicystic dysplastic kidney — is appropriate when counseling confirms negligible impact on long-term renal function (98% of children maintain normal GFR into adulthood).

Remember: the anomaly scan is one data point in a continuum of care. It complements — but does not replace — clinical judgment, serial assessments, and patient-centered values. Whether your scan shows typical anatomy or flags a finding requiring attention, you are supported by evidence-based protocols, multidisciplinary teams, and clear pathways for next steps. Your informed participation — from hydration before the scan to asking about PPV during counseling — directly contributes to safer, more personalized care.